drugset / Trial / NCT06031012

Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis

NCT06031012

Phase 3 Completed 138 enrolled Air Force Military Medical University, China
RandomizedParallel-groupSingle-blindPrevention

Summary

The goal of this study is to compare glutamine combined with thalidomide with glutamine in preventing radiation-induced oral mucositis. The aim of this study is to answer whether glutamine plus thalidomide could improve the median incidence time of grade 2 oral mucositis. Participants would be randomly divided into the two groups above mentioned.

Timeline

Start
2023-09-15
Primary completion
2025-10-31
Completion
2025-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutamine Other / unclassified Oral
Subject Thalidomide Other / unclassified 100 mg Oral

Indications